What is NDC 70771-1548?

70771-1548 is the product NDC for Erythromycin, Erythromycin 250 mg/1 tablet, film coated, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Erythromycin?

69 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Erythromycin NDC 70771-1548 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1548Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1548Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1548-1	70771154801	100 TABLET, FILM COATED in 1 BOTTLE (70771-1548-1)Marketed from Jun 30, 2023
70771-1548-3	70771154803	30 TABLET, FILM COATED in 1 BOTTLE (70771-1548-3)Marketed from Jun 30, 2023
70771-1548-5	70771154805	500 TABLET, FILM COATED in 1 BOTTLE (70771-1548-5)Marketed from Jun 30, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythromycin
Generic name (nonproprietary): erythromycin
Active ingredients: Erythromycin — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212693
Marketing start: Jun 30, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 70771-1548_35a32479-429b-4e71-9c5c-1e8ddbdff5e7SPL ID 35a32479-429b-4e71-9c5c-1e8ddbdff5e7SPL set ID 76608fdd-1248-4942-9518-fd8076244fa7RxCUI 197650, 598006UNII 63937KV33DUPC 0370771154913
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771154801 followed by a unit qualifier and the quantity

Package 70771-1548-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 21, 2023.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1548

What is NDC 70771-1548?: 70771-1548 is the product NDC for Erythromycin, Erythromycin 250 mg/1 tablet, film coated, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Erythromycin.
What is the active ingredient?: Erythromycin.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Erythromycin?: 69 other product NDCs are listed under this name. See all Erythromycin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Erythromycin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Sentiss Pharmaceuticals LLC	70244-031	70244-0031-0170244-0031-02
Erythromycin	Erythromycin 333 mg/1	Tablet, Delayed releaseOral	Torrent Pharmaceuticals Limited	13668-587	13668-0587-0113668-0587-0513668-0587-30
erythromycin	Erythromycin 250 mg/1	Capsule, Delayed release pelletsOral	Dr. Reddy's Labratories Inc.	75907-076	75907-0076-01
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	NuCare Pharmaceuticals,Inc.	68071-3992	68071-3992-02
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ARMAS PHARMACEUTICALS INC.	72485-670	72485-0670-3172485-0670-35
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ST. MARY'S MEDICAL PARK PHARMACY	60760-670	60760-0670-35
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Redpharm Drug	67296-2128	67296-2128-03
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Fera Pharmaceuticals, LLC	48102-057	48102-0057-11
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-397	46708-0397-3046708-0397-3146708-0397-91
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-398	46708-0398-3046708-0398-3146708-0398-91

All 70 Erythromycin NDCs

Other NDCs under ANDA 212693

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212693
Product	Strength	Form · route	Labeler	Product NDC
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Zydus Lifesciences Limited	70771-1549
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	70710-1047
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	70710-1048